<DOC>
	<DOCNO>NCT01076621</DOCNO>
	<brief_summary>This study conduct Europe . The primary aim observational study investigate occurrence bleed woman take 0.5 mg estradiol 0.1 mg norethisterone acetate ( NETA ) 12 month .</brief_summary>
	<brief_title>Observational Study Investigate Occurrence Bleeding Postmenopausal Women Treated With Estradiol/NETA 12 Months</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Norethindrone acetate</mesh_term>
	<mesh_term>Norethindrone</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<criteria>Informed consent , permit data process within scope study , obtain patient studyrelated activity Postmenopausal amenorrhoeic woman Treatment previously combine HRT discontinue least 3 month prior start 0.5 mg estradiol 0.1 mg norethisterone acetate treatment</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>